Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
AbCellera Biologics Inc. has filed 320 SEC EDGAR filings since 06 Apr 2017

SEC filing history

Showing 1-25 of 320 matching filings.

Per page
25
Current page
1
4

FORM 4

Filing date
14 Aug 2026
Reporting date
14 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2026
Reporting date
12 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Aug 2026
Reporting date
11 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-285367

424B5

Filing date
11 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Jul 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
11 Jun 2026
Reporting date
01 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 May 2026
Reporting date
14 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .